Your Cart ( 1 Item )

• Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy
  August 2019 | Volume 18 | Issue 8 | Original Article | 815 | Copyright © August 2019
  Linda Stein Gold MD,ª Edward Lain MD,^b Lawrence J. Green MD,^c Tina Lin PharmD,^d Robert Israel MD^e
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs